Mednet Logo
HomeHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?

2
3 Answers

Mednet Member
Mednet Member
General Internal Medicine · State Department Medical Services

I don't generally check a laboratory test to assess resolution. I go more by their improved clinical status and seeing them get back to baseline oxygen status. If I am trending a WBC or procal, I do like to see it trend down, but it's not the only lab I hang my hat on to decide if someone has resolv...

What adjunctive therapies to you recommend for symptom control in acute opioid withdrawal beyond full/partial opioid agonists?

4
2 Answers

Mednet Member
Mednet Member
Hospital Medicine · Oregon Health Sciences University (OHSU)

Here are some general recommendations below. I recommend asking the patient what symptoms are most bothersome or what they anticipate to be the most bothersome when prescribing adjuncts. I routinely recommend APAP/ibuprofen, and then usually prescribe something for anxiety and nausea. Tizanidine can...

What is your approach to antibiotic selection for bacterial species that demonstrate susceptibility to penicillins or cephalosporins on testing, but are known to harbor inducible AmpC resistance?

2 Answers

Mednet Member
Mednet Member
Infectious Disease · Christiana Care Health Syst

I will assess how long I am treating the person/infection, and go from there in terms of how likely I am to induce the AmpC based on the duration of treatment. For example, if it's a 7-day course for UTI or GN bacteremia, I may risk the penicillin/cephalosporin (based on susceptibilities, of course)...

What is your approach to antibiotic selection for bacterial species that demonstrate susceptibility to penicillins or cephalosporins on testing, but are known to harbor inducible AmpC resistance?

2 Answers

Mednet Member
Mednet Member
Infectious Disease · Christiana Care Health Syst

I will assess how long I am treating the person/infection, and go from there in terms of how likely I am to induce the AmpC based on the duration of treatment. For example, if it's a 7-day course for UTI or GN bacteremia, I may risk the penicillin/cephalosporin (based on susceptibilities, of course)...

What is your approach to monitoring blood parasite smears in an immunocompetent patient with babesiosis?

1 Answers

Mednet Member
Mednet Member
Infectious Disease · Perelman School of Medicine at the University of Pennsylvania

In an immunocompetent person the response rate to the treatment of acute babesiosis is extremely high and if a person is clinically improving follow-up smears are probably unnecessary. However, I generally check one at 48 hours to confirm a decrease in parasite burden. If that is favorable and the p...

How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?

3
3 Answers

Mednet Member
Mednet Member
Endocrinology · Duke Endocrinology Clinic

This is a great question with many ramifications, and I can only give an incomplete answer that includes personal opinion. First, what is the risk? The MESA Risk Score Calculator (check it out) gives a CAC percentile score as well as a 10-year risk. The 10-year risk may be low, but a high percentile...

How do you manage persistent rectal bleeding in the setting of rectal adenocarcinoma in a treatment-naive patient?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Rutgers Robert Wood Johnson Medical School

For a locally advanced rectal adenocarcinoma in the era of TNT, treatment of the tumor with either chemoradiation or chemotherapy upfront is reasonable, and both choices are known to palliate colorectal cancers effectively. With more severe bleeding, we often consider starting with chemoradiation th...

In an older adults with dementia-related behavioral symptoms refractory to nonpharmacological management in whom you are starting SSRI, do you ever consider a short course of antipsychotic medication to overlap with the initiation of SSRI while waiting for therapeutic effect?

1
1 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Beth Israel Deaconess Medical Center

The American Geriatric Society recommends that antipsychotics may be considered when behaviors do not respond to non-pharmacological management and the patient is at risk of harming themselves or others. Thereby, it may be reasonable to overlap short-term antipsychotic with SSRI initiation in older ...

What is your approach to medication selection and titration for post-operative pain?

1 Answers

Mednet Member
Mednet Member
Hospital Medicine · University of Chicago

My general approach to postoperative pain management is a stepwise multimodal strategy that prioritizes opioid-sparing therapy while tailoring medication choices to patient-specific and surgical factors. In practice, I try to balance three things: the expected pain mechanism related to the surgery, ...

How do you decide when and how often to reach out to patients with serious mental illness who are disengaging from care due to psychosocial stressors?

3
2 Answers

Mednet Member
Mednet Member
Psychiatry · University of Pittsburgh Medical Center

Outreach is always determined on a case-by-case basis, so it's difficult to give a definitive answer on this. Important factors to consider are the person's functional status, potential risk for harm without care, their decision-making ability, and the intensity of stressors. Obviously, those who ar...